A superoxide-mediated mitogen-activated protein kinase phosphatase-1 degradation and c-Jun NH2-terminal kinase activation pathway for luteolin-induced lung cancer cytotoxicity

Molecular Pharmacology

Volumn 81, Issue 4, 2012, Pages 549-555

  Bai, Lang ^a,b   Xu, Xiuling ^a   Wang, Qiong ^a,c   Xu, Shanling ^a   Ju, Wei ^a   Wang, Xia ^c   Chen, Wenshu ^a   He, Weiyang ^a   Tang, Hong ^b   Lin, Yong ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SUPEROXIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CANCER THERAPY; CELL KILLING; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; LUNG CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; HUMANS; LUNG NEOPLASMS; LUTEOLIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES;

EID: 84863338877     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.076653     Document Type: Article

References (35)

1. Bai L, Chen W, Wang X, Ju W, Xu S, and Lin Y (2009a) Attenuating Smac mimetic compound 3-induced NF-κB activation by luteolin leads to synergistic cytotoxicity in cancer cells. J Cell Biochem 108:1125-1131.
2. Bai L, Chen W, Chen W, Wang X, Tang H, and Lin Y (2009b) IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic-induced apoptosis in cancer cells. Mol Cancer Ther 8:1636-1645.
3. Birt DF, Hendrich S, and Wang W (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157-177. (Pubitemid 32913477)
4. Brondello JM, Pouysségur J, and McKenzie FR (1999) Reduced MAP kinase phosphatase- 1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517.
5. Chen W, Wang X, Zhuang J, Zhang L, and Lin Y (2007) Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis 28:2114-2121. (Pubitemid 47543370)
6. Chen YW, Huang SC, Lin-Shiau SY, and Lin JK (2005) Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26:1296-1306.
7. De Marchi U, Biasutto L, Garbisa S, Toninello A, and Zoratti M (2009) Quercetin can act either as an inhibitor or an inducer of the mitochondrial permeability transition pore: a demonstration of the ambivalent redox character of polyphenols. Biochim Biophys Acta 1787:1425-1432.
8. Garcia-Closas R, Agudo A, Gonzalez CA, and Riboli E (1998) Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 32:154-158. (Pubitemid 29081402)
9. Hirvonen T, Virtamo J, Korhonen P, Albanes D, and Pietinen P (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12:789-796. (Pubitemid 33010616)
10. Jemal A, Siegel R, Xu J, and Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300.
11. Ju W, Wang X, Shi H, Chen W, Belinsky SA, and Lin Y (2007) A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factoractivated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71:1381-1388. (Pubitemid 46658691)
12. Ko WG, Kang TH, Lee SJ, Kim YC, and Lee BH (2002) Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytother Res 16:295-298. (Pubitemid 34534964)
13. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, and Kolonel LN (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92:154-160. (Pubitemid 30089873)
14. Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, and Lee MT (2002) Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22:1615-1627. (Pubitemid 34839172)
15. Li Z, Xu X, Bai L, Chen W, and Lin Y (2011) Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J Biol Chem 286:21164-21172.
16. Liao Q, Guo J, Kleeff J, Zimmermann A, Büchler MW, Korc M, and Friess H (2003) Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology 124:1830-1845. (Pubitemid 36666779)
17. Lin A and Dibling B (2002) The true face of JNK activation in apoptosis. Aging Cell 1:112-116.
18. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, and Liu ZG (2004) Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279:10822-10828. (Pubitemid 38372695)
19. Lin Y, Devin A, Rodriguez Y, and Liu ZG. (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514-2526. (Pubitemid 29489643)
20. Lin Y, Shi R, Wang X, and Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8:634-646.
21. Liu R, Zheng HQ, Zhou Z, Dong JT, and Chen C (2009) KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem 284:16791-16798.
22. López-LázaroM(2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9:31-59.
23. Matsuo M, Sasaki N, Saga K, and Kaneko T (2005) Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull 28:253-259. (Pubitemid 40880004)
24. Michels G, Wätjen W, Niering P, Steffan B, Thi QH, Chovolou Y, Kampkötter A, Bast A, Proksch P, and Kahl R (2005) Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology 206:337-348. (Pubitemid 39601019)
25. Onn A, Tsuboi M, and Thatcher N (2004) Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib. Br J Cancer 91 (Suppl 2):S11-S17. (Pubitemid 39331427)
26. Osakabe N, Yasuda A, Natsume M, and Yoshikawa T (2004) Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 25:549-557. (Pubitemid 38499943)
27. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, and Wang JY (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 14:574-584. (Pubitemid 30159776)
28. Starkov AA (2008) The role of mitochondria in reactive oxygen species metabolism and signaling. Ann NY Acad Sci 1147:37-52.
29. Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH, and Burd R (2007) Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer 59:258-268. (Pubitemid 350230743)
30. Trachootham D, Alexandre J, and Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579-591.
31. Ueda H, Yamazaki C, and Yamazaki M (2003) Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion. Biol Pharm Bull 26:560-563. (Pubitemid 39663608)
32. Wang J, Zhou JY, and Wu GS (2007) ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells. Cancer Res 67:11933-11941.
33. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, and Lin Y (2006) 17-Allylamino- 17-demethoxygeldanamycin synergistically potentiates tumor necrosis factorinduced lung cancer cell death by blocking the nuclear factor-κB pathway. Cancer Res 66:1089-1095. (Pubitemid 43165977)
34. Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, Taylor PR, Virtamo J, and Albanes D (2004) Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol 160:68-76. (Pubitemid 38856803)
35. Wu GS (2007) Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev 26:579-585.